Joint Formulary & PAD

Fluocinolone acetonide - Uveitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravitreal implant
Associated Icons :
BNF SPC
ICB
NICE
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Fluocinolone acetonide
Indication :
Uveitis
Group Name :
Keywords :
Brand Names Include :
Iluvien
Important Information :
Ophthalmology specialists only.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Fluocinolone acetonide is used to treat.

Committee Recommendations (1)

The Area Prescribing Committee recommends fluocinolone acetonide as a treatment option in recurrent non-infectious uveitis in line with NICE TA590

Fluocinolone acetonide intravitreal implant will be considered RED on the traffic light system

Prescribing would be by hospital specialists only, in line with NICE TA596 using the Blueteq initiation and continuation forms.

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.